Thank you Vintage - that's helpful. I figured looking at the NEU economics that DXB had a larger market size. The additional information you shared more clearly demonstrates by how much and provides some good guidance on what DXB's MC could be if commercialised.
Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma, page-122
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $203.3M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 36.3¢ | $404.3K | 1.094M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 84998 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 21976 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |